A Study of Mitoxantrone Hydrochloride Liposome Injection Combination Therapy in Chinese Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
A Phase II Study of Chiauranib in Combine With Capecitabine in TNBC
- Status
- TERMINATED
- Phase
- PHASE2
Adjuvant CAPECITABINE in High Risk PSEUDOMYXOMA PERITONEI Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Rectal Artery Infusion Chemotherapy Combined With Anti-PD1 Antibody for MSS LARC
- Status
- UNKNOWN
- Phase
- PHASE2
Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers
- Status
- WITHDRAWN
- Phase
- PHASE1
Tisleizumab Combined With Lenvatinib and XELOX Regimen (Oxaliplatin Combined With Capecitabine) in the First-line Treatment of Advanced and Unresectable Biliary Tract Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer
- Status
- RECRUITING
- Phase
- PHASE2
An Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Gastric or Gastroesophageal Junction Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE2
SMMART Adaptive Clinical Treatment (ACT) Trial
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
PACE: PD-1 Antibody For dMMR/MSI-H Stage III Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Margetuximab Plus Tucatinib and Capecitabine in HER2-positive Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma (PRECAM)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks
- Status
- RECRUITING
- Phase
- PHASE3